I

Imu Biosciences jobs

🇬🇧 United Kingdom · Health
Latest round
$53M
3 Jun 2026
Open roles
1
1 posted in the last 30 days
Backed by
3 investors
IQ Capital, Molten Ventures and more
Hiring now

Open roles at Imu Biosciences

1 live role, newest first
Why join

Latest Imu Biosciences Signals

What they do

IMU Biosciences, a London-based biotechnology company, has raised over $53 million in an oversubscribed Series A funding round co-led by IQ Capital and Molten Ventures, with participation from the British Business Bank and others. The funding will support operational growth and the development of its clinical platform, particularly in advancing key clinical programs related to stem cell and solid organ transplants.

Why it matters

IMU Biosciences has developed a high-resolution immune system decoding platform that utilizes AI and machine learning to analyze immune data from over 25,000 individuals. This platform can analyze more than 100 million immune data points per sample, enabling a deeper understanding of disease mechanisms and personalized therapies.

Traction

The company is building one of the largest immune datasets globally, which positions it to transform disease understanding and treatment. Its target market includes researchers and clinicians focused on precision medicine and immunotherapy, particularly in the context of stem cell and organ transplants.

Where the market is going

IMU Biosciences is poised to disrupt traditional low-resolution immune profiling methods, which have limited the understanding of the immune system's role in health and disease. By establishing a universal standard for immune profiling, the company is betting on a significant shift towards precision medicine, challenging incumbents that rely on fragmented and mechanistic approaches.

Backed by
IQ CapitalMolten VenturesBritish Business Bank
Analysis updated 3 Jun 2026 Full deal history on MapCo →
Hiring at Imu Biosciences

Why Imu Biosciences is hiring

Imu Biosciences closed a $53M funding round in June 2026, with investors including IQ Capital, Molten Ventures and British Business Bank. It currently has 1 open role, 1 of them posted in the last 30 days, with hiring concentrated in London.

Teams hiring

Where Imu Biosciences hires

Also hiring

Similar Health companies hiring

FAQ

Imu Biosciences jobs: common questions

Is Imu Biosciences hiring?

Yes. Imu Biosciences has 1 open role on SuperAIJobs right now, including 1 posted in the last 30 days. The list is refreshed daily from Imu Biosciences’s own careers site.

Where are Imu Biosciences jobs located?

Most open roles at Imu Biosciences are in London.

Does Imu Biosciences hire remotely?

None of Imu Biosciences’s current roles are listed as remote, so expect to work from one of its offices.

How much has Imu Biosciences raised?

The latest round we track is a $53M funding round in June 2026. Investors include IQ Capital, Molten Ventures and British Business Bank. See the full deal history on MapCo.

What does Imu Biosciences do?

IMU Biosciences has developed a high-resolution immune system decoding platform that utilizes AI and machine learning to analyze immune data from over 25,000 individuals.

How do I apply for a job at Imu Biosciences?

Every role on this page links straight to Imu Biosciences’s own application page, so you apply directly — SuperAIJobs never sits in between.